---
figid: PMC5149523__fimmu-07-00550-g003
figlink: /pmc/articles/PMC5149523/figure/F3/
number: F3
caption: PD-1/PD-L1 blockade enhances tumor rejection by activating T cells. (Left)
  When PD-1/PD-L1 pathway is active, promotes survival of cancer cells via antiapoptotic
  signals mediated via PD-L1 and inhibits signaling pathways that lead to activation
  and expansion of T cells that recognize tumor antigens. Together, these events lead
  to impaired generation of T effector and memory cells and preferentiation differentiation
  of TEX and TReg cells, which promote tumor tolerance. (Right) Blocking the PD-1/PD-L1
  immune checkpoint pathway by anti-PD-1 or anti-PD-L1 antibodies suppresses cancer
  cell survival and enhances the antitumor responses of T cells, leading to tumor
  regression and rejection. In contrast to impaired TCR signaling induced by PD-1
  engagement, PD-1/PD-L1 blockade causes activation of T cells by increasing PI3K/Akt
  or Ras/MAPK pathways, promoting differentiation of effector and memory T cells and
  suppression of TEX and TReg differentiation.
pmcid: PMC5149523
papertitle: The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.
reftext: Kankana Bardhan, et al. Front Immunol. 2016;7:550.
pmc_ranked_result_index: '14588'
pathway_score: 0.9687763
filename: fimmu-07-00550-g003.jpg
figtitle: PD-1/PD-L1 blockade enhances tumor rejection by activating T cells
year: '2016'
organisms: Homo sapiens
ndex: 892b11d9-decb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5149523__fimmu-07-00550-g003.html
  '@type': Dataset
  description: PD-1/PD-L1 blockade enhances tumor rejection by activating T cells.
    (Left) When PD-1/PD-L1 pathway is active, promotes survival of cancer cells via
    antiapoptotic signals mediated via PD-L1 and inhibits signaling pathways that
    lead to activation and expansion of T cells that recognize tumor antigens. Together,
    these events lead to impaired generation of T effector and memory cells and preferentiation
    differentiation of TEX and TReg cells, which promote tumor tolerance. (Right)
    Blocking the PD-1/PD-L1 immune checkpoint pathway by anti-PD-1 or anti-PD-L1 antibodies
    suppresses cancer cell survival and enhances the antitumor responses of T cells,
    leading to tumor regression and rejection. In contrast to impaired TCR signaling
    induced by PD-1 engagement, PD-1/PD-L1 blockade causes activation of T cells by
    increasing PI3K/Akt or Ras/MAPK pathways, promoting differentiation of effector
    and memory T cells and suppression of TEX and TReg differentiation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT3
  - LAT
  - AKT2
  - PIK3R5
  - GRAP2
  - PIK3R6
  - PIK3R4
  - MAPK1
  - TRD
  - MAPK3
  - PIK3CD
  - PIK3CA
  - PIK3CB
  - LCK
  - MAP2K2
  - PIK3CG
  - PIK3R3
  - MAP2K1
  - MTOR
  - PDCD1
  - CD274
  - CD3G
  - CD3E
  - CD3D
  - TRA
  - TRB
  - RASGRP1
  - HRAS
  - PTPN6
  - PTPN11
  - NRAS
  - ZAP70
  - TRG
  - CD247
  - KRAS
  - Cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: LAT
  symbol: LAT
  source: hgnc_symbol
  hgnc_symbol: LAT
  entrez: '27040'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Gads
  symbol: GADS
  source: hgnc_alias_symbol
  hgnc_symbol: GRAP2
  entrez: '9402'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Lck
  symbol: LCK
  source: hgnc_symbol
  hgnc_symbol: LCK
  entrez: '3932'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PD-1/PD-L1blockade
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: RasGRP1
  symbol: RASGRP1
  source: hgnc_symbol
  hgnc_symbol: RASGRP1
  entrez: '10125'
- word: Ras-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: SHP-1
  symbol: SHP-1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: Ras-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ZAP-70
  symbol: ZAP-70
  source: hgnc_alias_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: Ras-GTP
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5149523__F3
redirect_from: /figures/PMC5149523__F3
figtype: Figure
---
